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Abstract
Background: The population of Fiji has experienced emergence of non-communicable disease (NCD) and a plateau in
life expectancy over the past 20 years.
Methods: A mini-STEPS survey (n = 2765) was conducted in Viseisei in Western Fiji to assess NCD risk factors (RFs)
in i-Taukei (Melanesians) and those of Indian descent aged 25–64 years (response 73 %). Hypertension (HT) was
defined as systolic blood pressure (BP) ≥140 mmHg or diastolic BP ≥90 mmHg or on medication for HT; type 2
diabetes mellitus (T2DM) as fasting plasma glucose ≥7.0 mmol/L or on medication for T2DM; and obesity as a body
mass index (kilograms/height(metres)2) ≥30. Data were age-adjusted to 2007 Fiji Census. Associations between RFs and
ethnicity/education were investigated. Comparisons with Fiji STEPS surveys were undertaken, and the absolute risk of a
cardiovascular disease (CVD) event/death in 10 years was estimated from multiple RF charts.
Results: NCD/RFs increased with age except excessive alcohol intake and daily smoking (women) which declined. Daily
smoking was higher in men 33 % (95 % confidence interval: 31–36) than women 14 % (12–116); women were more
obese 40 % (37–43) than men 23 % (20–26); HT was similar in men 37 % (34–40) and women 34 % (31–36), as was
T2DM in men 15 % (13–17) and women 17 % (15–19). i-Taukei men had an odds ratio (OR) of 0.41 (0.28–0.58) for T2DM
compared to Indians (1.00); and i-Taukei (both sexes) had a higher OR for obesity and low fruit/vegetable intake, daily
smoking, excessive alcohol intake and HT in females. Increasing education correlated with lesser smoking, but with
higher obesity and lower fruit/vegetable intake. Compared to the 2011 Fiji STEPS survey, no significant differences were
evident in obesity, HT or T2DM prevalences. The proportion (40–64 years) classified at high or very high risk (≥20 %) of a
CVD event/death (over 10 years) based on multiple RFs was 8.3 % for men (8.1 % i-Taukei, 8.5 % Indian), and 6.7 % for
women (7.9 % i-Taukei, 6.0 % Indian).
Conclusions: The results of the survey highlight the need for individual and community interventions to address the
high levels of NCD/RFs. Evaluation of interventions is needed in order to inform NCD control policies in Fiji and other
Pacific Island nations.
Keywords: Absolute cardiovascular risk, Non-communicable disease, Risk factors, Diabetes mellitus, Obesity, Fiji, Ethnic
groups
* Correspondence: r.taylor@unsw.edu.au
4School of Public Health and Community Medicine (SPHCM), Faculty of
Medicine, University of New South Wales (UNSW), Sydney, NSW 2052, Australia
Full list of author information is available at the end of the article
© 2016 Gyaneshwar et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gyaneshwar et al. BMC Public Health  (2016) 16:128 
DOI 10.1186/s12889-016-2806-6
Background
Non-communicable diseases (NCDs) are a major health
problem in Fiji causing considerable premature mortality
and limitation of improvement in life expectancy (LE) [1].
According to the World Health Organisation (WHO)
NCDs include cardiovascular disease (CVD), diabetes, can-
cer and chronic lung disease, and are contributed to by risk
factors (RFs) related to diet, exercise, and tobacco and alco-
hol consumption [2]. These RFs can be measured and
monitored through population prevalence surveys, such as
WHO STEPS surveys [3]. Control of NCD with lowering
of population RFs and reduction in premature adult mortal-
ity can be accomplished through primary prevention by
changing diet, exercise and consumption of tobacco and al-
cohol in populations using health promotion and policy
regulation of marketing and supply. NCD control also in-
volves the individual approaches of detection and treatment
of cases of NCD (secondary and tertiary prevention) and
management of those found to be at high risk of NCD,
especially because of multiple RFs (primary prevention).
The effectiveness of these interventions at a population
level in the context of Fiji is yet to be established.
Fiji is a multi-ethnic society (Melanesian 57 %, Indian
38 %) of 827,900 people at the 2007 Census [4]. NCDs such
as CVD and type 2 diabetes mellitus (T2DM) have been doc-
umented as public health concerns in Fiji since the 1970s
[5–7]. In 2012 an NCD RF survey was undertaken in the
Viseisei Health Zone, near Nadi in Fiji, to establish levels of
NCDs, RFs (behavioural, physical and biochemical) and ana-
lyse predictors (age, sex, ethnicity and education) and abso-
lute risk of a CVD event in this population. The purposes of
the survey were to establish baseline means and prevalences
of NCD and RFs, and absolute CVD risk, prior to a primary
health care community intervention; and to identify those
with NCD and at high risk for individual management. The
survey was coordinated by the Viseisei Sai Health Centre
which was developed as a charitable community health
centre in collaboration with the Fiji Ministry of Health (MoH)
and Fiji National University, College of Medicine, Nursing
and Health Sciences. It serves the community health needs
of a population of 7385, with a population ≥25 years of 3990
covering 14 census collection areas. The present study ana-
lyses the findings from this survey with respect to means
and prevalences of NCD RFs and absolute risk of a CVD
event, with differences by age, sex, and ethnicity, and com-
parisons with nationally representative data from Fiji STEPS
surveys [8; Fiji MoH, Fiji NCD STEPS Survey 2002 unit rec-
ord data supplied 2014, unpublished; Fiji MoH, Fiji NCD
STEPS Survey 2011 unit record data supplied 2014, unpub-
lished]. Apart from Papua New Guinea, Fiji has the largest
population (837,000 at the 2007 Census) of Pacific Island
States, where there is considerable similar morbidity and
mortality from CVD, diabetes, cancer and chronic lung
disease – especially in Polynesia and Micronesia.
Methods
Population and recruitment
The Viseisei Health Zone (VHZ) is near Nadi Inter-
national Airport, in the Western Division of Fiji. The sur-
vey was carried out in 2012 to measure baseline NCD and
RFs in the VHZ prior to the implementation of interven-
tions targeting NCD and RFs in the community.
All VHZ community members aged 25–64 years were in-
vited to participate if they were accessible by vehicle or a
walk of <1 kilometre. The community was informed of the
survey via community leaders, community health workers,
and other key members of the community. 2675 individuals
aged 25 to 64 years participated in the survey (72.7 % re-
sponse rate). The sample characteristics are shown in Table 1.
Ethics approval for the survey that included written consent
was approved by the Fiji National Research Committee.
Measurements
Participants were recruited to the study on the day preced-
ing the survey and advised to fast overnight. On the day of
the survey trained staff administered the behavioural ques-
tionnaire and took physical and biochemical measurements.
The questionnaire documented tobacco use: current
and daily smoking; alcohol consumption: in the last
12 months, and ≥4 drinks for women or ≥5 for men at ≥1
Table 1 Distribution (%) of characteristics of sampled adults
aged 25 to 64 years Viseisei and Fiji
Characteristics Viseisei, 2012 Fiji, 2011 STEPS Fiji, 2002 STEPS
(n = 2675) (n = 2387) (n = 4927)
% % %
Response rate 72.7 53.3 96.3
Age (years)
25–34 27.5 24.8 28.8
35–44 25.2 27.8 31.0
45–54 27.3 30.2 23.4
55–64 20.1 17.2 16.8
Sex
Male 43.9 44.0 41.0
Female 56.2 56.0 59.0
Ethnicity
I-Taukei 41.0 56.1 57.2
Indo-Fijian 58.4 43.9 42.8
Highest level of education
Primary or less 30.6 – 47.8
Any high school 35.0 – 44.3
Vocational training 24.1 – 4.7
University 10.3 – 3.2
Fiji NCD STEPS Survey 2002 [8; Fiji MoH, Fiji NCD STEPS Survey 2002 unit
record data supplied 2014, unpublished] and 2011 [Fiji MoH, Fiji NCD STEPS
Survey 2011 unit record data supplied 2014, unpublished]
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drinking session in the previous month; and intake of fruit
and vegetables (<5 servings/day), using a modified version
of the WHO STEPS instrument [3]. Height, weight, and
waist and hip circumferences were measured. Body mass
index (BMI) was defined as weight (kilograms) divided
by height (meters) squared (kg/m2). Participants with a
BMI ≥30 were classified as obese [3]. The WHO cut-
offs, indicating a substantially increased risk of meta-
bolic complications [9], were applied as measures of
central adiposity: waist circumference (men 102 cm;
women 88 cm) and waist-to-hip ratio (men 0.9 cm;
women 0.85 cm).
Three blood pressure (BP) readings were taken for
each respondent. Mean systolic blood pressure (SBP)
and diastolic blood pressure (DBP) were calculated
from the first two readings if the difference between
them was <10 mmHg, and from the second two read-
ings of the difference between the first and second
reading was ≥10 mmHg. Hypertension (HT) was de-
fined as a SBP ≥140 mmHg or DBP ≥90 mmHg or a re-
spondent currently taking medication for HT [3].
Fasting plasma glucose (FPG) was estimated using
Optium Xceed (Abbott) blood glucose system which is
calibrated to provide plasma glucose equivalents from
whole blood (either capillary or venous), and T2DM was
defined as FPG ≥7.0 mmol/L or taking medication for
T2DM [3]. This definition is the same as used for the
WHO Fiji 2011 STEPS survey. High total cholesterol
was defined as a total cholesterol ≥5.0 mmol/L or taking
medication for high cholesterol [3].
Ethnicity was defined as: i-Taukei (formerly indigenous
Fijians), or Indo-Fijian (Fijians of Indian descent). For
the present study only subjects aged 25–64 years and of
i-Taukei or Indo-Fijian ethnicity are included in the ana-
lysis. The main two ethnicities comprise 57 and 38 % re-
spectively of the Fiji 2007 Census population [4]. The
‘Other’ ethnicity was not included as it is heterogeneous
consisting of other Pacific Islanders, Europeans and
Asians, and comprises only 5 % of the total Fiji popula-
tion (2007 Census) [4]. Education was defined as highest
level of education achieved: primary school or lower, any
high school, vocational training, or university.
Data analysis
Means and prevalences were calculated for continuous
and categorical variables, respectively, with 95 % confi-
dence intervals. Of the 2675 participants, 2525 had height,
weight, waist and hip circumference measurements, 2549
had BP measurements and 2505 had FPG and cholesterol
measurements. Prevalences of NCD and RFs for VHZ
were estimated by age group for both sexes. A test for lin-
ear trend of age group for each NCD and RF was con-
ducted using age group as an ordinal independent variable
in linear or logistic regression for means and prevalences,
respectively. A statistically significant beta estimate from
the regression model for age group indicates a significant
age trend.
Estimates of NCD and RFs for the 2012 VHZ popula-
tion were weighted using the age, sex and ethnicity dis-
tribution of the 2007 Fiji Census population [Fiji Islands
Bureau of Statistics. Fiji Census 2007: Population table
by sex, age, ethnicity, urban/rural: supplied 2014, unpub-
lished]. These estimates were compared to those of the
2011 Fiji STEPS survey weighted to the age, sex, ethni-
city and rural/urban distribution of the 2007 Fiji Census
population. The Fiji 2002 STEPS survey was weighted to
the age, sex, ethnicity and rural/urban distributions of
the 1996 Fiji Census population. Weighting of STEPS
surveys to the most recent previous census population
structure improves representativeness.
For the Fiji 2002 STEPS, T2DM was defined as fasting
blood glucose of ≥6.1 mmol/L, since glucose was measured
from a whole blood sample using a system that did not
provide a plasma glucose equivalent. The mean fasting
blood glucose level was adjusted by a factor of 1.11 to give
a plasma level approximation, as recommended by the
International Federation of Clinical Chemistry (IFCC) [10].
Ethnic and education as determinants of NCD and RFs
in VHZ were investigated by comparing differences and
trends in RFs across categories. Ethnic comparisons (i-
Taukei, Indo-Fijians) are expressed as odds ratios (OR)
from logistic regression (adjusted for age as a continuous
variable). Analysis of NCD and risk factors and education
attainment considered sex as an effect modifier which was
accounted for by stratification. Age group and ethnicity
were considered as (potential) confounders and controlled
for in logistic regressions with the NCD or risk factor (RF)
as the dichotomous (y) dependent (outcome) variable, and
the confounders (age, ethnicity), and study factor (educa-
tion), as categorical independent (x) variables, except that
education was also used as an ordinal variable to deter-
mine linear trend.
The absolute CVD risk at the population level was esti-
mated by applying the WHO/International Society of
Hypertension (WHO/ISH) Western Pacific Region Group
B risk prediction charts to respondents aged 40 years and
over [11, 12]. The WHO/ISH risk prediction charts give a
percentage risk of a CVD event in 10 years based on an in-
dividual’s age, sex, smoking status, T2DM status, SBP and
total cholesterol levels [11, 12]. Individuals were categorised
as low (<10 %), medium (10 % to <20 %), high (20 % to
<30 %), and very high (≥30 %) risk of a CVD event.
Data were analysed using Statistical Analysis System
(SAS) version 9.4 [13] and Microsoft Excel [14] software.
Results
For men, mean waist circumference and waist:hip ratio,
but not BMI, increased with age, as did mean BP and HT
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Table 2 Males: non-communicable disease and risk factors by age group, 25 to 64 years in Viseisei and Fiji
NCD and risk factors Means and prevalences with 95 % confidence intervals
Age specific data and trend by age group Age std to: 2007 census 1996 census
Viseisei 2012 survey Fiji 2011* Fiji 2002*
25–34 yrs 35–44 yrs 45–54 yrs 55–64 yrs Age: linear
trend‡‡
25–64 std# 25–64 std‡ 25–64 std†
(n = 319) (n = 298) (n = 316) (n = 240) (n = 1173) (n = 1050) (n = 2019 )
Daily smoker % 34.2 33.6 31.0 29.2 0.92 (p = 0.16) 33.4 26.2 28.8
29.0–39.4 28.2–38.9 25.9–36.1 23.4–34.9 30.5–36.3 23.3–29.2 26.7–30.9
Excessive alcohol % 55.8 46.9 33.7 22.0 0.61 (p < 0.0001) 43.7 19.9 –
49.9–61.6 41.1–52.6 28.4–39.0 16.7–27.3 40.5–46.8 17.1–22.7
Low fruit & vegetable % 70.9 66.4 74.0 70.5 1.04 (p = 0.56) 72.4 47.8 –
65.9–75.9 61.0–71.9 69.1–78.8 64.7–76.3 69.7–75.1 44.2–51.3
Mean BMI kg/m2 25.0 26.4 26.5 25.6 0.23 (p = 0.11) 26.4 26.4 25.1
24.4–25.6 25.8–27.0 25.8–27.1 25.0–26.3 26.1–26.8 26.0–26.8 24.9–25.3
BMI ≥ 25 kg/m2 % 40.1 54.4 52.8 50.0 1.10 (p = 0.10) 56.7 58.7 46.3
34.7–45.5 48.7–60.0 47.3–58.4 43.7–56.3 53.6–59.8 55.6–61.9 44.0–48.6
BMI ≥ 30 kg/m2 % 15.9 19.9 25.4 19.0 1.12 (p = 0.11) 23.2 22.0 12.9
11.7–20.1 15.1–24.6 20.5–30.4 14.0–24.1 20.4–25.9 19.4–24.6 11.4–14.4
Mean waist cm 88.0 92.2 94.7 94.4 2.28 (p < 0.0001) 92.6 91.2 86.0
86.6–89.3 90.8–93.6 93.2–96.2 92.9–95.9 91.8–93.3 88.4–94.1 85.5–86.6
High waist %║ 10.7 18.4 29.1 23.8 1.40 (p < 0.0001) 21.9 18.4 9.3
7.1–14.2 13.8–23.0 23.9–34.2 18.3–29.3 19.3–24.6 16.0–20.7 8.0–10.6
Mean waist:hip 0.87 0.90 0.91 0.93 0.02 (p < 0.0001) 0.89 0.93 0.90
0.86–0.88 0.89–0.90 0.91–0.92 0.92–0.93 0.89–0.90 0.90–0.96 0.90–0.91
High§ waist:hip% 28.3 46.0 64.9 70.1 1.88 (p < 0.0001) 47.0 62.0 50.1
23.1–33.5 40.0–51.9 59.5–70.3 64.2–76.0 43.8–50.1 58.9–65.1 47.8–52.5
Mean SBP mmHg 125 129 135 143 5.91 (p < 0.0001) 131.4 132 127
123–126 127–130 133–137 139–146 130–132 131–133 127–128
Mean DBP mmHg 79.2 85.2 87.3 87.0 2.67 (p < 0.0001) 83.9 81.0 73.5
77.9–80.5 83.9–86.4 86.0–88.6 85.4–88.6 81.5–82.9 80.2–81.7 72.9–74.0
HT (%)¶ 23.2 34.9 47.3 55.4 1.61 (p < 0.0001) 37.2 36.6 19.1
18.3–28.1 29.3–40.6 41.7–53.0 49.0–61.8 34.2–40.3 33.3–40.0 17.4–20.9
Mean FBG mmol/L 5.3 5.6 6.5 7.0 0.60 (p < 0.0001) 5.8 6.4 6.2
5.1–5.5 5.4–5.8 6.2–6.8 6.6–7.3 5.7–5.9 6.1–6.8 6.1–6.4
Diabetes % ** 6.3 11.6 27.6 35.6 2.05 (p < 0.0001) 15.1 13.8 16.3
3.5–9.1 7.7–15.4 22.4–32.7 29.5–41.8 13.0–17.2 11.4–16.2 13.8–18.9
Mean chol mmol/L 4.6 5.2 5.3 5.3 0.22 (p < 0.0001) 5.0 – 5.4
4.5–4.8 5.0–5.3 5.2–5.5 5.1–5.5 4.9–5.1 5.3–5.5
High chol % †† 9.5 18.4 24.5 22.1 1.37 (p < 0.0001) 17.5 – –
6.1–12.9 13.7–23.0 19.5–29.4 16.7–27.4 15.1–19.8
Fiji data from WHO STEPS surveys 2002 [Fiji MoH, Fiji NCD STEPS Survey 2002 unit record data supplied 2014, unpublished] and 2011 [Fiji MoH, Fiji NCD STEPS
Survey 2011 unit record data supplied 2014, unpublished]. Prevalence or mean with 95 % confidence intervals. Statistically significant linear trend p < 0.05 are in bold
BMI body mass index, BP blood pressure, SBP systolic BP, DBP diastolic BP, HT hypertension, FBG fasting plasma glucose, chol total plasma cholesterol
‡‡Linear trend represents average change in odds ratio between age groups for prevalence estimates and average change in measurement between age groups
for mean estimates. ║Waist circumference >102 cm for males. § Waist to hip ratio ≥0.9 for males
Std *Standardised for age and ethnicity to Fiji 2007 census population [4, Fiji Islands Bureau of Statistics. Fiji Census 2007: Population table by sex, age, ethnicity,
urban/rural: supplied 2014, unpublished]; ‡Standardised for age, ethnicity and rural/urban locality to Fiji 2007 census population. †Standardised for age, ethnicity
and rural/urban locality to Fiji 1996 census population [15]; ¶ Systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg and/or on medication for HT
** Viseisei 2012 and Fiji STEPS 2011 [Fiji MoH, Fiji NCD STEPS Survey 2011 unit record data supplied 2014, unpublished]: FPG ≥7.0 mmol/L and/or on medication
for diabetes; Fiji STEPS 2002 [Fiji MoH, Fiji NCD STEPS Survey 2002 unit record data supplied 2014, unpublished]: FBG ≥6.1 mmol/L and/or on medication for
diabetes. ††Total cholesterol level ≥5.0 mmol/L and/or on medication for high cholesterol
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Table 3 Females: non-communicable disease and risk factors by age group, 25 to 64 years in Viseisei and Fiji
NCD and risk factors Means and prevalences with 95 % confidence intervals
Age specific data and trend by age group Age std to: 2007 census 1996 census
Viseisei 2012 survey Fiji 2011* Fiji 2002*
25–34 yrs 35–44 yrs 45–54 yrs 55–64 yrs Age: linear
trend‡‡
25–64 std# 25–64 std‡ 25–64 std†
(n = 319) (n = 298) (n = 316) (n = 240) (n = 1173) (n = 1050) (n = 2019)
Daily smoker % 7.7 10.4 3.9 4.0 0.75 (p = 0.004) 8.8 5.9 4.5
5.1–10.2 7.3–13.5 2.0–5.7 1.8–6.3 7.1–10.5 4.3–7.4 3.8–5.2
Excessive alcohol % 10.4 7.9 1.2 1.3 0.45 (p < 0.0001) 7.6 2.8 –
7.4–13.3 5.1–10.6 0.2–2.3 0.0–2.7 6.0–9.2 1.8–3.8
Low fruit & vegetable % 63.1 66.6 66.5 74.2 1.16 (p = 0.005) 68.7 43.6 –
58.5–67.7 61.8–71.4 61.9–71.1 69.2–79.2 66.3–71.2 40.5–46.6
Mean BMI kg/m2 27.0 29.1 28.6 29.0 0.56 (p = 0.0005) 28.9 29.3 28.0
26.3–27.7 28.5–29.8 27.9–29.3 28.3–29.6 28.6–29.3 28.9–29.7 27.8–28.3
BMI ≥ 25 kg/m2 % 52.0 69.6 62.7 71.0 1.20 (p = 0.0006) 69.2 74.8 68.0
47.2–56.8 64.9–74.3 58.0–67.4 65.9–76.2 66.7–71.6 72.4–77.3 66.2–69.8
BMI ≥ 30 kg/m2 % 28.1 41.4 37.1 39.7 1.15 (p = 0.006) 39.9 41.7 33.5
23.6–32.6 36.3–46.5 32.4–41.8 34.0–45.3 37.1–42.6 39.0–44.4 31.8–35.3
Mean waist cm 87.1 92.2 92.2 94.7 2.31 (p < 0.000) 92.5 92.8 87.1
85.6–88.6 90.8–93.7 90.8–93.5 93.2–96.2 91.6–93.3 91.8–93.8 86.6–87.6
High waist %║ 46.4 63.0 60.1 68.0 1.30 (p < 0.0001) 61.9 63.6 47.3
41.4–51.3 58.0–68.0 55.4–64.9 62.7–73.4 59.3–64.6 60.7–66.5 45.4–49.2
Mean waist:hip 0.84 0.86 0.87 0.89 0.02 (p < 0.0001) 0.86 0.89 0.86
0.83–0.85 0.85–0.86 0.86–0.88 0.88–0.90 0.86–0.87 0.88–0.89) 0.86–0.87
High§ waist:hip % 46.6 54.2 64.4 72.9 1.46 (p < 0.0001) 58.8 72.9 54.8
41.6–51.6 49.0–59.4 59.7–69.0 67.7–78.0 56.1–61.5 70.3–75.6 52.9–56.7
Mean SBP mmHg 117 126 139 152 11.6 (p < 0.0001) 130.2 129 125
116–118 124–128 136–141 149–155 129–132 128–131 124–126
Mean DBP mmHg 76.3 81.5 85.2 89.9 4.46 (p < 0.0001) 82.2 80.5 74.4
75.3–77.3 80.3–82.8 83.9–86.5 88.4–91.5 81.5–82.9 79.8–81.3 73.9–74.9
HT (%)¶ 10.0 27.1 47.9 74.3 2.88 (p < 0.0001) 33.7 33.3 20.0
7.0–12.9 22.5–31.7 43.0–52.8 69.3–79.3 31.2–36.2 30.4–36.1 18.6–21.5
Mean FBG mmol/L 5.4 6.1 7.2 6.9 0.59 (p < 0.0001) 6.2 6.4 6.4
5.3–5.6 5.8–6.3 6.9–7.6 6.6–7.2 6.1–6.3 6.2–6.6 6.2–6.2
Diabetes % ** 5.3 14.5 30.5 33.7 1.98 (p < 0.0001) 17.3 16.7 16.6
3.1–7.6 10.8–18.2 25.9–35.0 28.2–39.1 15.3–19.3 14.5–18.9 14.6–18.6
Mean chol mmol/L 4.3 4.7 5.2 5.5 0.42 (p < 0.0001) 4.8 – 5.1
4.2–4.5 4.5–4.8 5.1–5.3 5.4–5.7 4.7–4.9 5.0–5.1
High chol % †† 5.3 11.4 21.2 29.7 1.92 (p < 0.0001) 14.7 – –
3.1–7.6 8.0–14.7 17.2–25.2 24.4–34.9 12.8–16.6
Fiji data from WHO STEPS surveys 2002 [Fiji MoH, Fiji NCD STEPS Survey 2002 unit record data supplied 2014, unpublished] and 2011 [Fiji MoH, Fiji NCD STEPS
Survey 2011 unit record data supplied 2014, unpublished]. Prevalence or mean with 95 % confidence intervals. Statistically significant linear trend p < 0.05 are
in bold
BMI body mass index, BP blood pressure, SBP systolic BP, DBP diastolic BP, HT hypertension, FBG fasting plasma glucose, chol total plasma cholesterol
‡‡Linear trend represents average change in odds ratio between age groups for prevalence estimates and average change in measurement between age groups
for mean estimates. ║Waist circumference >88 cm for females. § Waist to hip ratio ≥0.85 for females
Std *Standardised for age and ethnicity to Fiji 2007 census population [4]; ‡Standardised for age, ethnicity and rural/urban locality to Fiji 2007 census population
[4, Fiji Islands Bureau of Statistics. Fiji Census 2007: Population table by sex, age, ethnicity, urban/rural: supplied 2014, unpublished]. †Standardised for age,
ethnicity and rural/urban locality to Fiji 1996 census population [15]; ¶ Systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg and/or on medication for HT
**Viseisei 2012 and Fiji STEPS 2011 [Fiji MoH, Fiji NCD STEPS Survey 2011 unit record data supplied 2014, unpublished]: FPG ≥7.0 mmol/L and/or on medication
for diabetes; Fiji STEPS 2002 [Fiji MoH, Fiji NCD STEPS Survey 2002 unit record data supplied 2014, unpublished]: FBG ≥6.1 mmol/L and/or on medication for
diabetes. ††Total cholesterol level ≥5.0 mmol/L and/or on medication for high cholesterol
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prevalence, mean FPG and T2DM prevalence and blood
cholesterol (mean and prevalence of elevated levels); ex-
cessive alcohol intake declined with age (Table 2). For
women, all NCD RFs increased with age, except daily
smoking and excessive alcohol intake, which declined with
age (Table 3). Daily smoking, excessive alcohol use and
low fruit and vegetable intake were more prevalent among
men than women. Women had higher means and preva-
lences of measures of obesity than men (BMI 28.9 vs 26.4;
obesity 39.9 % vs 23.2 %), but there were no sex differ-
ences in prevalences of HT (32–33 %) or T2DM (15–
17 %) (Tables 2 and 3).
Compared to the 2011 Fiji STEPS survey, men in the
VHZ survey had higher rates of daily smoking, excessive
alcohol intake, and lower fruit and vegetable intake, while
the means and prevalences of other RFs were similar
(Table 2). Women in the VHZ survey had a higher preva-
lence of excessive alcohol intake and lower fruit and vege-
table consumption, but lower prevalence of high waist-to-
hip ratio (Table 3). There were no significant differences
in obesity (based on BMI), HT or T2DM prevalences.
Comparison of both the VHZ 2012 and Fiji 2011 STEPS
surveys with the Fiji STEPS 2002 indicate an increase in
obesity and HT in both sexes over the decade.
Based on age-adjusted ORs, i-Taukei men were sig-
nificantly more likely than Indo-Fijian men to have low
fruit and vegetable intake, obesity, or high waist cir-
cumference, but less likely to have T2DM (Table 4). For
women, i-Taukei had higher ORs compared to Indo-
Fijians for daily smoking, excessive alcohol intake, low
fruit and vegetable intake, obesity, high waist circum-
ference and waist-hip ratio, and HT prevalence; but the
OR for prevalence of T2DM and high cholesterol were
not significantly different (Table 4). Adjusted for age
and ethnicity, increasing education in men showed a
statistically significant trend for lower daily smoking,
but a significant positive trend for obesity, high waist
circumference, low fruit and vegetable intake, and HT.
For women, increasing education showed significant
negative linear trend for high waist-to-hip ratio and low
fruit and vegetable intake, but a positive trend for ex-
cessive alcohol intake (Table 4).
Table 4 Association of non-communicable disease risk factors with ethnicity and education, Viseisei Health Zone, Fiji, 2012
NCD and Risk factors by sex Odds ratio (95 % CI)
Ethnicity (age adj) Education (age and ethnicity adjusted)
I-Taukei Indo-Fijian Primary or less Any high school Vocational training University Test for trend+
Males
Daily smoking 1.19 (0.93–1.53) 1.00 3.09 (1.83–5.22) 2.45 (1.50–4.00) 1.91 (1.14–3.20) 1.00 0.73 (p < 0.0001)
Excessive alcohol 1.13 (0.87–1.45) 1.00 1.50 (0.93–2.44) 1.90 (1.22–2.97) 1.44 (0.90–2.30) 1.00 0.89 (p = 0.10)
Low fruit & vegetable 2.39 (1.81–3.16) 1.00 2.29 (1.41–3.73) 1.43 (0.92–2.22) 1.69 (1.06–2.69) 1.00 0.81 (p = 0.005)
Obesity BMI≥ 30 kg/m2 6.88 (4.85–9.76) 1.00 0.35 (0.19–0.64) 0.41 (0.24–0.70) 0.67 (0.39–1.16) 1.00 1.45 (p < 0.0001)
High waist* circumference 5.09 (3.64–7.11) 1.00 0.40 (0.21–0.75) 0.62 (0.35–1.10) 0.90 (0.50–1.61) 1.00 1.40 (p = 0.0004)
High waist-hip ratio† 0.89 (0.68–1.15) 1.00 0.65 (0.40–1.07) 0.89 (0.56–1.41) 0.87 (0.54–1.41) 1.00 1.14 (p = 0.08)
HT‡ 1.10 (0.85–1.42) 1.00 0.64 (0.39–1.05) 0.63 (0.40–1.01) 0.89 (0.55–1.44) 1.00 1.18 (p = 0.03)
Diabetes║ 0.41 (0.28–0.58) 1.00 1.21 (0.53–2.76) 1.54 (0.69–3.43) 2.11 (0.93–4.78) 1.00 1.12 (p = 0.26)
High cholesterol§ 1.08 (0.79–1.49) 1.00 0.70 (0.38–1.31) 0.71 (0.40–1.28) 1.00 (0.55–1.81) 1.00 1.16 (p = 0.11)
Females
Daily smoking 51.2 (16.1–162.5) 1.00 6.04 (2.02–18.09) 3.56 (1.33–9.54) 6.35 (2.39–16.84) 1.00 0.80 (p = 0.09)
Excessive alcohol 22.02 (8.82–54.96) 1.00 0.83 (0.34–2.03) 0.34 (0.17–0.70) 0.93 (0.50–1.75) 1.00 1.36 (p = 0.03)
Low fruit & vegetable 2.34 (1.84–2.97) 1.00 1.86 (1.16–2.98) 1.22 (0.81–1.84) 1.49 (0.81–1.84) 1.00 0.88 (p = 0.06)
Obesity BMI≥ 30 kg/m2 4.65 (3.67–5.89) 1.00 1.07 (0.65–1.76) 1.15 (0.74–1.77) 1.34 (0.86–2.09) 1.00 1.03 (p = 0.65)
High waist * circumference 5.10 (3.97–6.56) 1.00 1.58 (0.97–2.59) 1.60 (1.03–2.48) 1.47 (0.94–2.30) 1.00 0.90 (p = 0.13)
High waist-hip ratio† 1.97 (1.57–2.47) 1.00 1.77 (1.11–2.82) 1.78 (1.18–2.69) 1.32 (0.87–2.00) 1.00 0.83 (p = 0.006)
HT‡ 1.51 (1.17–1.94) 1.00 1.20 (0.68–2.13) 1.22 (0.72–2.08) 1.08 (0.63–1.86) 1.00 0.94 (p = 0.43)
Diabetes║ 0.77 (0.58–1.03) 1.00 1.26 (0.62–2.54) 1.33 (0.69–2.59) 1.28 (0.65–2.53) 1.00 0.97 (p = 0.73)
High cholesterol§ 1.33 (0.99–1.80) 1.00 0.94 (0.47–1.88) 0.84 (0.44–1.61) 0.98 (0.51–1.89) 1.00 1.03 (p = 0.80)
Statistically significant p < 0.05 Odds Ratios are in bold. OR for trend <1.00 indicates decreasing association with increasing education, and OR > 1.00 indicates
increasing association with increasing education. + Linear trend as average increase or decrease in weighted OR across ordered categories
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension
*Waist circumference >102 cm for males and >88 cm for females. †Waist to hip ratio ≥0.9 for males and ≥0.85 for females
‡ Systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg and/or on medication for HT
║FPG ≥ 7.0 mmol/L and/or on medication for diabetes. §Total cholesterol level ≥5.0 mmol/L and/or on medication for cholesterol
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Absolute CVD risk categories in those aged over
40 years were calculated from risk charts based on age,
sex, BP, T2DM, smoking and cholesterol categories. For
men, 5.3 % (95%CI: 3.6–6.9) were classified at very high
risk (≥30 %) and 3.0 % (95%CI: 1.7–4.2) at high risk
(≥20– < 30 %) of a CVD event (total 8.3 % at high or
very high risk); for women 4.0 % (95 % CI: 2.7–5.2) were
classified at very high risk, and 2.7 % (95 % CI: 1.7–3.7)
at high risk of a CVD event (total at 6.7 % at high or
very high risk) (Table 5). There were no significant eth-
nic differences in those classified at high or very high
risk of a CVD event.
Discussion
Prevalence of RFs in the VHZ in 2012 varied by age, sex,
ethnicity and education level. Most RF and NCD preva-
lences increased with age, except excessive alcohol in-
take and daily smoking (women) which declined with
increasing age. Daily smoking prevalence was higher in
men than women, but women were more obese than
men. The prevalences of HT and T2DM were similar in
both sexes. i-Taukei men had less than half the preva-
lence of T2DM than Fijians of Indian descent; and i-
Taukei had higher ORs for indices of obesity, low fruit/
vegetable intake (both sexes), and daily smoking, exces-
sive alcohol intake and HT in females (age-adjusted). In-
creasing education correlated with lower smoking rates,
but higher ORs for obesity, high waist circumference,
waist-hip ratio and lower fruit and vegetable intake
(adjusted for age and ethnicity). Compared to the Fiji
2011 STEPS survey, alcohol intake, low fruit/vegetable
intake and daily smoking (men) were higher in VHZ
than nationally, but no significant differences in obesity
(based on BMI), HT or T2DM prevalences (adjusted for
age, ethnicity, urban/rural). The proportion (40–64
years) classified at high risk or very high risk (≥20 %) of
CVD event (over 10 years) based on multiple RF estima-
tion was 8.3 % for men and 6.7 % for women.
Despite lower obesity using the standard WHO defin-
ition, Fijians of Indian descent had higher prevalence of
diabetes mellitus than i-Taukei, associated with the well
described propensit y of south Asians to develop dia-
betes at lower BMI than several other ethnicities [15].
Compared to Fijians of Indian descent, i-Taukei had
lower fruit and vegetable intake, and higher tobacco and
alcohol consumption. These differences require further
investigation and indicate that targeted heath education
is required. Differences by education suggest that health
promotion messages concerning tobacco smoking are
having an effect, but, so far, not those related to diet.
To simplify analyses and improve comparability, the age
groups were restricted to 25–64 years, and the ‘Other’ eth-
nic group was excluded from analyses. The ‘Other’ ethni-
city is heterogeneous consisting of other Pacific Islanders,
Europeans and Asians, and comprises only 5 % of the total
Fiji population (2007 Census) [4].
In order to improve national representativeness the Fiji
STEPS surveys were adjusted (using case weights) to the
Table 5 Proportions of the population in various cardiovascular risk categories by age, sex and ethnicity, Viseisei Health Zone, Fiji, 2012
Sex/Age (years)/Ethnicity Cardiovascular event* risk category
Very high risk: ≥30 % High risk: 20 % to <30 % Medium risk: 10 to <20 % Low risk: <10 %
% (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Males
40–49 (n = 282) 1.1 (0–2.3) 0.7 (0–1.7) 12.1 (8.3–15.9) 86.2 (82.1–90.2)
50–59 (n = 271) 4.4 (2.0–6.9) 5.5 (2.8–8.3) 18.8 (14.2–23.5) 71.2 (65.8–76.6)
60–64 (n = 99) 25.3 (16.7–33.8) 5.1 (0.7–9.4) 24.2 (15.8–32.7) 45.5 (35.6–55.3)
40–64† (n = 652) 5.3 (3.6–6.9) 3.0 (1.7–4.2) 16.3 (13.5–19.2) 75.4 (72.1–78.7)
I-Taukei† (n = 259) 4.3 (2.0–6.7) 3.8 (1.6–6.0) 13.1 (9.0–17.2) 78.7 (73.8–83.6)
Indo-Fijian† (n = 385) 6.0 (3.8–8.2) 2.5 (1.0–3.9) 18.2 (14.3–22.1) 73.3 (68.9–77.8)
Females
40–49 (n = 405) 1.7 (0.5–3.0) 0.5 (0–1.2) 1.7 (0.5–3.0) 96.0 (94.2–97.9)
50–59 (n = 357) 4.8 (2.6–7.0) 2.5 (0.9–4.1) 6.2 (3.7–8.7) 86.6 (83.0–90.1)
60–64 (n = 120) 12.5 (6.6–18.4) 14.2 (7.9–20.4) 8.3 (3.9–13.3) 65.0 (56.5–73.5)
40–64† (n = 882) 4.0 (2.7–5.2) 2.7 (1.7–3.7) 4.0 (2.8–5.3) 89.3 (87.4–91.3)
I-Taukei† (n = 315) 4.2 (2.0–6.3) 3.7 (1.8–5.6) 4.3 (2.2–6.4) 87.9 (84.4–91.3)
Indo-Fijian† (n = 563) 3.9 (2.4–5.4) 2.1 (1.0–3.2) 3.9 (2.4–5.5) 90.1 (87.7–92.4)
*Risk of cardiovascular event or death risk over 10 years based on
WHO/International Society of Hypertension Western Pacific Region Group B risk prediction charts
WHO/ISH Risk Prediction Charts for 14 WHO Epidemiological Sub-Regions. WHO 2007 [11]
† Age adjusted to total Fiji population at the 2007 Census [4]
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closest previous Fiji census which were used for the sam-
pling frame, since the actual age, sex, ethnic and rural/
urban structure of the survey respondents differed to some
extent. Thus the 2007 Fiji Census [Fiji Islands Bureau of
Statistics. Fiji Census 2007: Population table by sex, age,
ethnicity, urban/rural: supplied 2014, unpublished] was
used for the WHO Fiji 2011 STEPS survey and the 1996
Fiji Census [16] was used for the WHO Fiji 2002 STEPS
survey [8, Fiji MoH, Fiji NCD STEPS Survey 2002 unit rec-
ord data supplied 2014, unpublished].
The VHZ 2012 survey is adjusted for age and ethnicity
by sex to the 2007 Fiji Census [Fiji Islands Bureau of
Statistics. Fiji Census 2007: Population table by sex, age,
ethnicity, urban/rural: supplied 2014, unpublished] in
order to minimise confounding when comparing with
the WHO Fiji 2011 STEPS survey [8, Fiji MoH, NCD
STEPS Survey 2011 tabulations supplied 2014, unpub-
lished] for these variables.
Compared to Fiji 2011 STEPS survey, alcohol intake,
low fruit/vegetable intake and daily smoking (men) were
higher in VHZ than nationally, but there were no signifi-
cant differences in obesity (based on BMI), HT or
T2DM prevalences - adjusted for age, ethnicity, urban/
rural to the Fiji 2007 Census. Comparison of both the
VHZ 2012 and Fiji 2011 STEPS surveys with the Fiji
STEPS 2002 suggest an increase in obesity and HT in
both sexes over the decade, although the 2002 STEPS is
adjusted to the previous Fiji Census (1996) and some of
this increase may be related to demographic changes.
Relatively high prevalences of NCD and RFs in Fiji
were documented by population NCD and RF surveys
from the 1960s [17] and 1980s [18], as well as the WHO
NCD Fiji STEPs surveys 2002 and 2011 [8, Fiji MoH, Fiji
NCD STEPS Survey 2011 unit record data supplied
2014, unpublished]. Studies of trends over 30 years (to
2011) in diabetes and obesity [19], and in mean BP &
HT [20] from population surveys in Fiji indicate contin-
ued increases in these RFs, commensurate with trends in
premature adult mortality and proportional mortality
from CVD [1, 21].
WHO STEPS surveys in 13 Pacific states during the
first decade of this century indicate a median HT preva-
lence of 22 % (inter-quartile range 17–26 %) [22], com-
pared with the 33 % in VHZ in 2012 from the present
study using the same criteria. WHO STEPS surveys in
the same Pacific states during this period suggest a me-
dian T2DM prevalence of 23 % (inter-quartile range 18–
32 %) [22], compared with the 16 % from the present
study. Recent studies of the relatively isolated Island of
Wallis have documented significant increases in cardio-
vascular risk over 1980–2009 [23].
In Fiji and other Pacific countries such as Tonga [24,
25] and Nauru [26], NCDs are producing sufficient pre-
mature mortality to result in plateaux in LE over
decades [27]. Increasing CVD proportional mortality in
Fiji is already having an effect [21], as premature adult
mortality has increased, and LE has not improved since
1985 in either sex [21], or ethnicity [1]. The situation is
worst in i-Taukei women where recent evidence indi-
cates LE has decreased [1].
Considerable premature adult mortality from CVD and
other NCDs also contributes to relatively low and static
LE trends in Indigenous minorities in developed countries,
such as Australian Aboriginals [28, 29] and New Zealand
Maori [30], and in some Eastern European countries (es-
pecially Russia) and central Asian states [31, 32]. Such
plateaux in LE are often at lower levels and more pro-
longed than experienced by Australia [33–35], New Zea-
land, and other English-speaking during their NCD
epidemic last century.
Conclusions
The 2012 VHZ survey of NCDs and RFs resulted in
findings which were quite similar to the 2011 national
Fiji STEPS survey with respect to obesity, T2DM and
HT, while smoking, alcohol consumption and low fruit
and vegetable intake were more prevalent in VHZ. These
relatively high prevalences of NCD and RFs convey risk
of CVD episodes and death, and contribute to premature
adult mortality and the observed plateaux in LE in Fiji
since the 1980s.
The previous and present initiatives in Fiji for NCD pre-
vention and control that require strengthening include:
the SNAP (smoking, nutrition, alcohol, physical activity)
framework for individual and community health promo-
tion directed at behavioural NCD RFs; personal diabetes
record books; WHO PEN protocols for RF detection and
management for individuals and communities; mass
media campaigns; the ‘Wellness cascade’ for health educa-
tion/promotion using a life course approach; and the use
of volunteer community health workers in primary health
care, including NCD prevention and control [36, 37]. It is
crucial to evaluate the effectiveness of these initiatives on
NCD and RF prevalences and premature mortality from
CVD, diabetes and other NCDs in order to continually re-
vise and refresh approaches to prevention and control.
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